ASX Share rice
Sun 16 Aug 2020 - 01:55:am (Sydney)

EXL Share Price

ELIXINOL GLOBAL LIMITEDEXLHousehold & Personal Products

EXL Company Information

Name:

Elixinol Global Limited

Sector:

Healthcare

Industry:

Drug Manufacturers—Specialty & Generic

Address:

Gateway Tower Sydney Australia 2000

Phone:

61 2 4044 4585

Co-Founder & Chairman:

Mr. Paul Elliot Benhaim

Chief Financial Officer:

Mr. Ron Dufficy

Group CEO & Director:

Mr. Oliver Horn

Account Director of Investor Relations Department:

Glen Zurcher

Global Gen. Counsel & Company Sec.:

Ms. Teresa Cleary

Company Overview:

Elixinol Global Limited, through its subsidiaries, manufactures and distributes industrial hemp-based dietary supplements and skincare products. The company distributes hemp-derived cannabidiol products in North and South America, Europe, Asia, and the Pacific Region. It also acts as a wholesaler, retailer, manufacturer, and exporter of bulk and branded raw materials, and finished products; offers hemp seeds, hemp protein, hemp oil, and hemp flour; and owns organic hemp skincare range under the SATIVATM Skincare name, Grounded frozen burger brand, Essential Hemp snack bars, and the Hemp Man brand. The company is based in Sydney, Australia.

EXL Share Price Information

Shares Issued:

192.84M

Market Capitalisation:

$32.78M

Revenue (TTM):

$27.18M

Revenue Per Share (TTM):

$0.21

Earnings per Share:

$-0.09

Operating Margin (TTM):

$-0.87

Return On Assets (TTM):

$-0.11

Return On Equity (TTM):

$-0.52

Quarterly Revenue Growth (YOY):

0.173

Gross Profit(TTM):

$15.62M

Diluted Earnings Per Share (TTM):

$-0.627

EXL CashFlow Statement

CashFlow Date:

2019-12-31

Investments:

$-17,932,000

Change To Liabilities:

$-9,147,000

Total Cashflow From Investing Activities:

$-17,932,000

Net Borrowings:

$-729,000

Net Income:

$-82,928,000

Total Cash From Operating Activities:

$-51,066,000

Depreciation:

$2.45M

Sale Purchase Of Stock:

$-2,827,000

Capital Expenditures:

$11.15M

EXL Income Statement

Income Date:

2019-12-31

Income Before Tax:

$-73,617,000

Net Income:

$-82,928,000

Gross Profit:

$15.62M

Operating Income:

$-23,766,000

Interest Expense:

$6K

Income Tax Expense:

$-7,620,000

Total Revenue:

$27.18M

Total Operating Expenses:

$39.39M

Cost Of Revenue:

$11.56M

EXL Balance Sheet

Balance Sheet Date:

2019-12-31

Intangible Assets:

$11.77M

Total Liabilities:

$9.69M

Total Stockholder Equity:

$111.41M

Other Current Liabilities:

$1.94M

Total Assets:

$121.07M

Common Stock:

$188.77M

Other Current Assets:

$417K

Retained Earnings:

$-86,544,000

Other Liabilities:

$35K

Good Will:

$28.23M

Other Assets:

$4.31M

Cash:

$20.24M

Total Current Liabilities:

$6.01M

Property - Plant & Equipment:

$17.01M

Net Tangible Assets:

$71.42M

Long-Term Investments:

$8.40M

Total Current Assets:

$51.36M

Net Receivables:

$2.21M

Short-Term Investments:

$69.71M

Inventory:

$21.31M

Accounts Payable:

$1.79M

Non Currrent Assets (Other):

$69.71M

Short-Term Investments:

$69.71

Non Current Liabilities Total:

$3.68M

EXL Share Price History

EXL News

26 Mar, 2020
Elixinol, a global hemp derived CBD brand, announced it has named Tom Siciliano as the organization's new CEO Americas effective immediately. Siciliano is charged with leading Elixinol's refined strategy on hemp derived CBD in the Americas region.
17 Mar, 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
19 Sep, 2019
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...